XML 54 R45.htm IDEA: XBRL DOCUMENT v3.19.2
Shareholders' Equity - Summary of Inputs Used in the Measurement of the Fair Values and the Related Fair Values at the Grant Dates (Detail)
6 Months Ended
Jun. 30, 2019
yr
€ / shares
Key management personnel [member]  
Disclosure of terms and conditions of share-based payment arrangement [line items]  
Expected volatility (weighted-average) 87.58%
Contractual life | yr 10
Expected dividends 0.00%
Key management personnel [member] | Bottom of range [member]  
Disclosure of terms and conditions of share-based payment arrangement [line items]  
Fair value at grant date € 6.07
Share price at grant date 9.83
Exercise price € 9.83
Expected dividends 0.00%
Risk-free interest rate (based on government bonds) 2.13%
Key management personnel [member] | Top of range [member]  
Disclosure of terms and conditions of share-based payment arrangement [line items]  
Fair value at grant date € 7.60
Share price at grant date 12.49
Exercise price € 12.49
Expected dividends 0.00%
Risk-free interest rate (based on government bonds) 2.74%
All other employees [member]  
Disclosure of terms and conditions of share-based payment arrangement [line items]  
Expected volatility (weighted-average) 87.11%
Contractual life | yr 10
Expected dividends 0.00%
All other employees [member] | Bottom of range [member]  
Disclosure of terms and conditions of share-based payment arrangement [line items]  
Fair value at grant date € 6.15
Share price at grant date 9.83
Exercise price € 9.83
Expected dividends 0.00%
Risk-free interest rate (based on government bonds) 2.02%
All other employees [member] | Top of range [member]  
Disclosure of terms and conditions of share-based payment arrangement [line items]  
Fair value at grant date € 8.62
Share price at grant date 14.19
Exercise price € 14.19
Expected dividends 0.00%
Risk-free interest rate (based on government bonds) 2.65%